Concepedia

Yejin Sung

YS

Statistics

Publications

3

Citations

71

H-Index

3

Active since

2020

Affiliations

Korea Institute of Science and Technology(Current)

Korea University

Yonsei University

Yejin Sung is an author at Korea Institute of Science and Technology specializing in pharmacology, oncology, and growth factor signaling.

Publications per year

2020–2023

3

Publications

3

Therapeutic effect of NLRP3 inhibition on hearing loss induced by systemic inflammation in a CAPS-associated mouse model

Ji-Hyun Ma, Eunju Lee, Sung-Hyun Yoon et al. · EBioMedicine · 2022 · 41 citations · Full text

, , +17

Predicting response to anti-EGFR antibody, cetuximab, therapy by monitoring receptor internalization and degradation

Yejin Sung, Seung Taek Hong, Mihue Jang et al. · Biomaterials · 2023 · 17 citations

, , +17

Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug

Han Young Kim, Sang Hoon Um, Yejin Sung et al. · Journal of Controlled Release · 2020 · 13 citations

, , +17

1–3 of 3